PIS
NSPR icon

POM Investment Strategies’s InspireMD NSPR Stock Holding History

POM Investment Strategies’s Portfolio NSPR Stock Details NSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,667
Closed -$4.38K – 312
2024
Q4 		$4.38K Buy
+1,667
New +$4.49K ﹤0.01% 230

Other funds holding NSPR

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
AF
Affiance Financial St. Louis Park, Minnesota $695M AUM 17.33% 1-Year Est. Return
HA
Huntleigh Advisors St. Louis, Missouri $585M AUM 50.58% 1-Year Est. Return

POM Investment Strategies's NSPR Position: Q1 2025 in Review

POM Investment Strategies sold out of InspireMD (NSPR) in Q1 2025, closing a stake of 1,667 shares — an estimated $4.38K sold.

POM Investment Strategies first reported a position in NSPR in Q4 2024 and held it in 1 quarter. The position peaked at $4.38K in Q4 2024. 35 funds tracked by Wall St. Rank hold NSPR as of Q1 2025.

  • POM Investment Strategies reported no remaining InspireMD position as of Q1 2025 after selling out during the quarter.
  • POM Investment Strategies sold 1,667 InspireMD shares in Q1 2025, an estimated $4.38K.
  • POM Investment Strategies first reported a position in InspireMD in Q4 2024 and held it in 1 quarter.
  • POM Investment Strategies's InspireMD position peaked at $4.38K in Q4 2024.
  • 35 funds tracked by Wall St. Rank held InspireMD as of Q1 2025.

Based on POM Investment Strategies's 13F filing for Q1 2025, filed 30 Apr 2025.